Melvin D. Yahr

21.7k total citations · 4 hit papers
125 papers, 17.6k citations indexed

About

Melvin D. Yahr is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Melvin D. Yahr has authored 125 papers receiving a total of 17.6k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Neurology, 31 papers in Cellular and Molecular Neuroscience and 19 papers in Molecular Biology. Recurrent topics in Melvin D. Yahr's work include Parkinson's Disease Mechanisms and Treatments (55 papers), Neurological disorders and treatments (36 papers) and Neuroscience and Neuropharmacology Research (14 papers). Melvin D. Yahr is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (55 papers), Neurological disorders and treatments (36 papers) and Neuroscience and Neuropharmacology Research (14 papers). Melvin D. Yahr collaborates with scholars based in United States, Israel and United Kingdom. Melvin D. Yahr's co-authors include Margaret M. Hoehn, Roger C. Duvoisin, Christopher G. Goetz, Robert G. Holloway, Carl Counsell, Cristina Sampaio, Glenn T. Stebbins, Charity G. Moore, Olivier Rascol and Gregor K. Wenning and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Melvin D. Yahr

125 papers receiving 16.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinsonism

1967 10.0k citations Margaret M. Hoehn, Melvin D. Yahr profile →
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease

2004 1.8k citations Christopher G. Goetz, Werner Poewe et al. Movement Disorders profile →
Parkinsonism

1998 735 citations Margaret M. Hoehn, Melvin D. Yahr profile →
Treatment of Parkinsonism With Levodopa

1969 472 citations Melvin D. Yahr, Roger C. Duvoisin et al. Archives of Neurology profile →

Peers

Countries citing papers authored by Melvin D. Yahr

Since Specialization

Citations

This map shows the geographic impact of Melvin D. Yahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin D. Yahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin D. Yahr more than expected).

Fields of papers citing papers by Melvin D. Yahr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin D. Yahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin D. Yahr. The network helps show where Melvin D. Yahr may publish in the future.

Co-authorship network of co-authors of Melvin D. Yahr

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin D. Yahr. A scholar is included among the top collaborators of Melvin D. Yahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin D. Yahr. Melvin D. Yahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson?s activity 2004 ·Journal of Neural Transmission ·Martin R. Gluck, Lourdes Santana, (unknown), Melvin D. Yahr	28
2	Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease breakdown → 2004 ·Movement Disorders ·Christopher G. Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Carl Counsell, Nir Giladi, Robert G. Holloway, Charity G. Moore, Gregor K. Wenning, Melvin D. Yahr, (unknown)	1768
3	Selegiline in the treatment of Parkinson's disease: its impact on orthostatic hypotension 2003 ·Parkinsonism & Related Disorders ·Kirsty Bhattacharya, Soraya Nouri, C. Warren Olanow, Melvin D. Yahr, Horacio Kaufmann	22
4	Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings 2003 ·Parkinsonism & Related Disorders ·Melvin D. Yahr, (unknown), Dushyant P. Purohit	62
5	Intrastriatal iron perfusion releases dopamine: an in-vivo microdialysis study 2002 ·Journal of Neural Transmission ·(unknown), T. Brannan, Melvin D. Yahr	4
6	COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against l-dopa toxicity in vitro 2001 ·Brain Research ·(unknown), Alessandro Di Rocco, (unknown), (unknown), Teodoro Bottiglieri, Susan Bressman, Melvin D. Yahr	16
7	Focal tremor following striatal infarct?A case report 1999 ·Movement Disorders ·T. Brannan, Melvin D. Yahr	1
8	Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation 1998 ·Brain Research ·T. Brannan, (unknown), Melvin D. Yahr	7
9	Postencephalitic parkinsonism – a review 1998 ·Journal of Neural Transmission ·J. Casals, T. S. Elizan, Melvin D. Yahr	74
10	Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism 1997 ·Journal of Neural Transmission ·T. Brannan, (unknown), Melvin D. Yahr	26
11	Elevated striatal dopamine levels following administration ofd-DOPA and its α-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat 1996 ·Brain Research ·T. Brannan, (unknown), Melvin D. Yahr	5
12	The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning 1996 ·Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section ·Michele Tagliati, Iván Bódis-Wollner, Melvin D. Yahr	83
13	Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease 1995 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Iván Bódis-Wollner, J. C. Borod, (unknown), Carlton Haywood, Sarah A. Raskin, L. Mylin, Martin J. Sliwinski, Abigail Falk, Melvin D. Yahr	25
14	Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: An in vivo study 1994 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·T. Brannan, (unknown), Melvin D. Yahr	1
15	Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease 1994 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Catherine Mytilineou, P. Werner, S. Molinari, Alessandro Di Rocco, G. Cohen, Melvin D. Yahr	70
16	A multicenter double‐blind placebo‐controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease 1994 ·Movement Disorders ·C. Warren Olanow, Stanley Fahn, Manfred D. Muenter, Harold L. Klawans, Howard I. Hurtig, Matthew Stern, Ira Shoulson, Roger Kurlan, J. David Grimes, Joseph Jankovic, Margaret M. Hoehn, Charles H. Markham, (unknown), O. M. Reinmuth, (unknown), (unknown), Robert Feldman, Linda A. Hershey, Melvin D. Yahr	166
17	Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains 1991 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Marietta R. Issidorides, Catherine Mytilineou, (unknown), Melvin D. Yahr	16
18	Effect of dietary protein on striatal dopamine formation following L-dopa administration: An in vivo study 1991 ·Neuropharmacology ·T. Brannan, (unknown), Melvin D. Yahr	17
19	Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated? 1988 ·Journal of Neural Transmission ·J. J. M. Askenasy, Melvin D. Yahr	14
20	Treatment of Parkinsonism With Levodopa breakdown → 1969 ·Archives of Neurology ·Melvin D. Yahr, Roger C. Duvoisin, (unknown), Robert E. Barrett, Margaret M. Hoehn	472

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact